Login to Your Account



GLYBERA PRICE TAG: $1M

First patient to be treated with the first commercial gene therapy

By Nuala Moran
Staff Writer

Wednesday, March 4, 2015
LONDON – It is more than two years since Glybera received marketing approval, but finally the first patient is lined up to be treated with the first commercial gene therapy.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription